Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by longondmxon Oct 20, 2009 3:43pm
567 Views
Post# 16405109

RE: Don't get too excited..

RE: Don't get too excited..I'll bite...even though every bit of me says to ignore this poster...

If that were true, could it be only those research employees involved with Pennsaid?  Since Nuvo's agreement with Covidien includes Covidien taking over all future development/expansion of Pennsaid there is no need for a research department any more with respect to Pennsaid/Pennsaid technology?  

I thought another poster - a reliable one - had confirmed layoffs did not happen.  Sorry, I don;t feel like wading through all of the latest posts to look myself.

 
Bullboard Posts